Navigation Links
Golub Capital Provides $29.5 Million GOLD Facility in Support of the Recapitalization of ExtruMed
Date:3/26/2008

NEW YORK, March 26 /PRNewswire/ -- Golub Capital today announced that it has provided a $29.5 million one-loan debt financing (through Golub Capital's proprietary GOLD facility) in support of the recapitalization of ExtruMed, a market leader providing precision tubing solutions to the medical industry. Founded in 1990, and based in Placentia, Calif., ExtruMed's products are used in medical devices and technology serving various therapy areas including cardiology, vascular therapies, endosurgery, neurology, Ob/Gyn and urology. GOLD financings are proprietary Golub Capital One-Loan Debt facilities.

ExtruMed has been owned by Inverness Graham Investments and Wedbush Capital Partners since September 2005. The debt provided by Golub Capital will be used to refinance the company's existing debt and provide a cash dividend to the sponsors.

"We are very excited to have closed our first transaction with two private equity sponsors of the caliber of Inverness Graham and Wedbush Capital. We are pleased that we were able to provide them with the appropriate solution for their financing needs," said Golub Capital Managing Director Charlie Riceman. "ExtruMed is a true leader in its field. We have been extremely impressed with the deep knowledge and experience of the ExtruMed management team and are excited to watch ExtruMed continue to build out its capabilities and grow."

"We are pleased to close our first transaction with Golub Capital. The flexibility in structure and spirit of partnership demonstrated by Golub has contributed to a very efficient process. We are pleased to have them as partners in ExtruMed and look forward to future transactions together." says Scott Kehoe, a Managing Principal at Inverness Graham Investments.

Golub Capital lends to broad range of U.S.-based mid-market companies and initially invests between $5 million and $75 million with additional capital available for growth.

About Golub Capital

Golub Capita
'/>"/>

SOURCE Golub Capital
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Capital BlueCross Receives Prestigious Brand Excellence Award From The Blue Cross & Blue Shield Association
2. Super Model Cindy Crawford will be Honored at DKMS Linked Against Leukemia Gala on May 7th at Capitale
3. St. Alcuin Montessori School Announces $5 Million Capital Campaign Gift
4. InforMedix Retains Murdock Capital Partners
5. LifeMasters Strengthens Capital Structure with $15 Million in Funding from Existing Investors
6. Avista Capital Partners Enhances Energy Practice With Appointment of Gerhard Kurz
7. HealthpointCapital, LLC Appoints Stephen H. Hochschuler, M.D. as Clinical Advisor
8. MaxLife Fund Corp. and Capital Growth Planning Inc., sign a joint venture agreement
9. Ener1 to Present at February Roth Capital 20th Annual OC Growth Stock Conference
10. CryoCor to Present at Roth Capital Partners 20th Annual OC Growth Stock Conference
11. Boston Scientific Completes Sale of Fluid Management and Venous Access Businesses to Avista Capital Partners
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:New Executive Leadership and CEO Announced for BiPar Sciences 2ThromboGenics Announces Start of Phase II Trial of Microplasmin for the Treatment of Age-Related Macular Degeneration (AMD) 2ThromboGenics Announces Start of Phase II Trial of Microplasmin for the Treatment of Age-Related Macular Degeneration (AMD) 3ThromboGenics Announces Start of Phase II Trial of Microplasmin for the Treatment of Age-Related Macular Degeneration (AMD) 4Federal Judge Rejects GlaxoSmithKline's Claims of Privilege 2Tianyin Pharmaceutical Co Inc Provides Fiscal 2010 Guidance 49332 1Tianyin Pharmaceutical Co Inc Provides Fiscal 2010 Guidance 49332 2Tianyin Pharmaceutical Co Inc Provides Fiscal 2010 Guidance 49332 3Tianyin Pharmaceutical Co Inc Provides Fiscal 2010 Guidance 49332 4Tianyin Pharmaceutical Co Inc Provides Fiscal 2010 Guidance 49332 5Arena Pharmaceuticals to Present at the Piper Jaffray Fourth Annual Europe Conference 49329 1Arena Pharmaceuticals to Present at the Piper Jaffray Fourth Annual Europe Conference 49329 2Arena Pharmaceuticals to Present at the Piper Jaffray Fourth Annual Europe Conference 49329 3HLTH Corporation and WebMD Health Corp Announce Agreement to Merge 49326 1HLTH Corporation and WebMD Health Corp Announce Agreement to Merge 49326 2HLTH Corporation and WebMD Health Corp Announce Agreement to Merge 49326 3HLTH Corporation and WebMD Health Corp Announce Agreement to Merge 49326 4HLTH Corporation and WebMD Health Corp Announce Agreement to Merge 49326 5